L-Mesitran honey products show antibacterial efficacy against antibiotic resistant bacteriae

Dec. 14, 2010 - PRLog -- Maastricht (NL) - Antibiotic resistance in Gram-positive as well as Gram-negative micro organisms is a growing problem worldwide. The prevalence of Methicillin resistant Staphylococcus aureus (MRSA) and Gram negatives producing an Extended Spectrum beta-lactamase (ESBL) is steadily increasing during the past decades. Antibiotic use is generally considered the main risk factor for antibiotic resistance. Efforts to reduce the use of antimicrobial agents are therefore warranted.

Dr. Ellen Stobberingh, PhD, an authority on antibiotic resistant bacteriae from the Maastricht University Hospital (AZM) in The Netherlands researched the antibacterial activity of the honey based products L-Mesitran Ointment and Soft. The honey products have been used in wound care for a number of years with great success.

The AZM Medical Microbiology Department tested the activity of both products against clinical isolates of Staph. aureus, Ps. aeruginosa, Kl. pneumoniae and E. Coli;  all bacteriae were antibiotic resistant and Kl. pneumoniae and E. Coli were ESBL producing strains.

The honey based products were tested using controls and comparisons against other honey products (also Manuka). The test results were obtained in a study that had the product and bacteriae incubated for a 24hour period.

L-Mesitran Soft showed to have the highest antibacterial activity against all the bacteriae at the lowest dilution, followed by L-Mesitran Ointment. The outcome of this test proves that L-Mesitran Ointment and Soft are very effective against antibiotic resistant bacteriae. This is a valuable contribution in our efforts to reduce the use of antibiotics. The test also shows that L-Mesitran is the best choice in combating antibiotic resistant bacteriae.

Compared to antibiotics, the use of honey products is safe and without adverse effects for the treatment of infected wounds. The tested products can achieve the same goal as antibiotics: reducing the bacterial burden in a wound. Honey has as an added benefit that it can speed up wound healing and therefore (apart from lower material costs) can provide a cost effective therapy. Honey, and in particular the tested products, does therefore provide an attractive alternative for the use of (topical) antibiotics in the management of wound infections

# # #

L-Mesitran® is the leading brand of wound care products of the Triticum company.The company was founded in July 2000, based upon the research of Dr.Theo Postmes, Phd in Biochemistry. His research at the University Hospital of Maastricht (NL) and publications (e.g. in The Lancet) led to the conclusion that honey is capable of healing wounds fast and efficient.

The company patented these unique products and in 2002 L-Mesitran® was the first CE-marked product based on honey on the European market.The L-Mesitran® products are now available in almost all European countries and several countries outside the EU. On our distributors page you will find all our partners worldwide.

To this day, L-Mesitran® strives to be the pioneer in the wound care market with honey based products.Our aim is to provide high quality honey based wound care products for fast and efficient wound healing.

L-Mesitran® offers a naturalbreakthrough in woundcare.